In gonadectomized (GDX) animals replaced with subcutaneous steroid implants supplying physiological levels of testosterone (T; l-l 0 rig/ml), the magnitude of adrenocorticotropic hormone (ACTH) and cot-ticosterone (B) responses to restraint was negatively correlated with the level of T replacement, reflecting the inhibitory influence of T on hypothalamic-pituitary-adrenal (HPA) responses to stress. Although T had no effect on restingstate levels of corticotropin-releasing hormone (CRH) in the median eminence, arginine vasopressin (AVP) levels were significantly lower in GDX animals replaced with higher T levels, and the magnitude of the ACTH response to restraint was strongly correlated with median eminence levels of AVP. High physiological levels of T increased glucocorticoid receptor binding in the medial preoptic area (MPOA), with no effect on mineralocorticoid receptor binding or on glucocot-ticoid receptor binding in other regions. Crystalline T or B implants in the MPOA significantly reduced plasma ACTH and B responses to 10 min of restraint stress compared with cholesterol-implanted controls. Moreover, B or T MPOA implants also decreased resting-state levels of AVP but not CRH in the median eminence, and these effects were correlated with ACTH responses to restraint. Finally, lesioning the MPOA blocked the inhibitory effects of high peripheral T levels on ACTH and B responses to restraint. Thus, variations in the magnitude of HPA responses to stress among males are explained in part by individual differences in circulating T levels, and the MPOA is a critical site for this effect via the inhibition of hypophysial AVP.
In gonadectomized (GDX) animals replaced with subcutaneous steroid implants supplying physiological levels of testosterone (T; l-l 0 rig/ml), the magnitude of adrenocorticotropic hormone (ACTH) and cot-ticosterone (B) responses to restraint was negatively correlated with the level of T replacement, reflecting the inhibitory influence of T on hypothalamic-pituitary-adrenal (HPA) responses to stress. Although T had no effect on restingstate levels of corticotropin-releasing hormone (CRH) in the median eminence, arginine vasopressin (AVP) levels were significantly lower in GDX animals replaced with higher T levels, and the magnitude of the ACTH response to restraint was strongly correlated with median eminence levels of AVP. High physiological levels of T increased glucocorticoid receptor binding in the medial preoptic area (MPOA), with no effect on mineralocorticoid receptor binding or on glucocot-ticoid receptor binding in other regions. Crystalline T or B implants in the MPOA significantly reduced plasma ACTH and B responses to 10 min of restraint stress compared with cholesterol-implanted controls. Moreover, B or T MPOA implants also decreased resting-state levels of AVP but not CRH in the median eminence, and these effects were correlated with ACTH responses to restraint. Finally, lesioning the MPOA blocked the inhibitory effects of high peripheral T levels on ACTH and B responses to restraint. Thus, variations in the magnitude of HPA responses to stress among males are explained in part by individual differences in circulating T levels, and the MPOA is a critical site for this effect via the inhibition of hypophysial AVP.
Key words: stress; testosterone; ACTH; glucocorticoid receptors; arginine vasopressin; medial preoptic area Most studies examining hypothalamic-pituitary-adrenal (HPA) function have been performed in the male because this gender is believed to represent a comparatively stable gonadal environment. Gonadal activity in the male, however, is indeed subject to variation, as evidenced by marked changes in testosterone (T) release as a function of social and reproductive status and in response to stress. The manner in which such naturally occurring variations in circulating T levels affect HPA function remains unclear. Males typically show reduced adrenocorticotropic hormone (ACTH) and corticosterone (B) responses to stress (Lestoat et al., 1970; L,e Mevel et al., 1978 L,e Mevel et al., , 1979 Kant et al., 1983) compared with that shown in females, an effect that is attributed in part to the inhibitory effects of testosterone (T). Gonadectomized (GDX) males show increased plasma ACTH and B responses to several forms of stress (Viau and Meaney, 1991b; Handa et al., 1994) . This effect is reversed with T or dihydrotestosterone (DHT), the reduced nonaromatizable form of T, indicating an androgen receptor-mediated effect (Viau and Meaney, 1991b; Handa et al., 1994) .
Corticotrophs express few if any androgen receptors (Dubois et al., 1978; Thieulant and Duvall, 1985) and minimal aromatase activity (McEwen, 1980) . Thus, the inhibition of stress-induced ACTH release by androgens is unlikely to be explained by direct actions of T or its estrogen byproducts at the level of the pituitary. Existing studies suggest central effects of gonadal steroids on HPA activity; females show higher bioassayable levels of hypothalamic corticotropin-releasing hormone (CRH) (Hiroshige et al., 1973) and increased levels of CRH mRNA in the paraventricular nucleus (PVN) (Watts and Swanson, 1989 ). This sex difference reflects a stimulatory effect of estrogen on CRH synthesis and release; acute elevations in plasma estrogen levels in females increase CRH mRNA and content in the hypothalamus (Bohler, 1990; Viau and Meaney, 1992) .
Chronic DHT treatment decreases the stimulatory effects of chronic gonadectomy on CRH immunoreactivity in the PVN of the hypothalamus (Bingaman et al., 1994) . Whether this finding reflects changes in CRH activity within the medial dorsal parvocellular region of the PVN, the source of hypophysiotropic CRH, remains to be resolved. Androgen receptors are present within the PVN but are essentially localized to cell types giving rise to descending brainstem and spinal cord projections (Simerly et al., 1990; Zhou et al., 1994) . Thus, the central sites at which androgens modulate HPA activity remain elusive. Handa et al. (1994) reported that decreased ACTH responses to stress after androgen treatment in GDX males are not associated with changes in glucocorticoid receptor binding capacity or affinity in the hippocampus, hypothalamus, and pituitary. Nevertheless, glucocorticoids regulate HPA activity in several brain regions in addition to these target sites (Kovacs and Makara, 1988; Sapolsky et al., 1990; Dallman et al., 1993; Diorio et al., 1993) . Thus, T regulation of glucocorticoid feedback and HPA Vim and Meaney . MPA and HPA Activity J. Neurosci., March 1, 1996 , 76(5):1866 -1876 1887 activity may involve alterations in glucocorticoid receptor levels outside the hippocampus and hypothalamus. Thus, we examined the extent to which variations in plasma T levels regulate plasma ACTH and B responses to stress in intact adult males and in GDX rats replaced with physiological doses of T, median eminence CRH and arginine vasopressin (AVP) content, and glucocorticoid receptor binding. The results of the latter study directed our attention to the medial preoptic area (MPOA) of the brain. Thus, we also examined the effects of local steroid implants and lesions of this structure on HPA responses to stress. Our findings indicate that subtle differences in plasma T levels have a significant impact on several elements of the HPA axis, an effect that is mediated in part at the level of the MPOA.
MATERIALS AND METHODS
Animals. The animals used were male Long-Evans hooded rats (Charles River Canada, St. Constant, Quebec, Canada) weighing -300 gm at testing. Animals were group-housed (4icage) with food and drinking water available ad lib&urn. Room temperature was maintained at 20-22°C with a 12 hr light/dark schedule (lights on 8 A.M. to 8 P.M.). Animals were bilaterally gonadectomized and implanted with subcutaneous SI-LASTIC capsules [0.062 inner diameter (i.d.), 0.125 outer diameter (o.d.); Dow Corning, Midland, MI] filled with crystalline T (Smith et al., 1977) . These capsules were designed to provide circulating T levels over a range of l-7 @ml in a 300 gm rat. HPA activity was studied 2 weeks after castration and implantation of T-filled capsules. Hormone measures during restraint were obtained from blood samples collected from an indwelling right jugular vein SILASTIC cannula (0.025 i.d., 0.047 o.d.; Dow Corning) that exited from the back of the neck, and blood samples were replaced with an equal volume of normal saline (0.9%) via the same route. Four days before testing, animals were anesthetized with the inhalation anesthetic methoxyflurane (Metofane; Pitman-Moore, Washington Crossing, NJ) and implanted with jugular catheters. They were single-housed for the remainder of the study.
Restraint stress experiments. In all cases, restraint was performed between 12 P.M. and 3 P.M. Prestress blood samples were taken from rats within 30 set of removal from the cage. Animals then were placed immediately into hemicylindrical, ventilated, Plexiglas tubes for a period of 10 min, after which blood was sampled at 0, 10,20,30, and 60 min after stress. Blood samples (300 ~1) were collected in iced tubes containing 10 pi of EDTA and aprotinin (Trasylol; Miles Canada), centrifuged at 3000 X g for 10 min, and stored at -80°C until assayed.
In experiments including measurements of median eminence peptide content, animals were given a 4 d rest period after the termination of stress. At the conclusion of this period, the animals were killed rapidly by decapitation. We removed the median eminence under a dissection microscope (Cue110 et al., 1973) by peeling off the pia matter and, while holding the stalk with fine forceps, dissecting the lateral and frontal borders defined by capillary loops. The stalk was then removed, rapidly frozen on dry ice, and stored at -80°C.
Corticosteroid receptor binding assays. Animals were killed by decapitation 16 hr after adrenalectomy. Brains were removed quickly and placed on ice, and the hippocampus, hypothalamus, pituitary, frontal cortex, septum, amygdala, and MPOA were dissected and stored at -80°C until assayed. The tissue was homogenized in TEDGM buffer [30 mM Tris, 1 mM EDTA, 1 IIIM dithiothreitol, 10% (v/v) glycerol, and 10 mM sodium molybdate, pH 7.41 and centrifuged at 105,000 X g. Protein concentrations of the supernatants were determined using the method of Bradford (1976 receptors, respectively, separation of bound from free ligand was performed on Sephadex LH-20 columns, after which the bound fraction was counted as discussed above. The specific binding is expressed as fmol/mg protein.
MPOA steroid implants. Cannulae (24.gauge) containing 100 yg of pure crystalline B or T were bilaterally implanted into the MPOA under pentobarbital anesthesia and tightly secured to the skull with dental acrylic. The following stereotaxic coordinates (from Paxinos and Watson, 1982) were used with bregma as the anterior-posterior (AP) reference to the dura: AP, 0.6 mm; ventral, 8.0 mm, and ? 0.7 mm from the midline. Control animals were implanted with cannulae containing cholesterol (CHOL) as a control for nonspecific steroidal effects. In this study, the animals were gonadectomized and replaced with low T levels (-1 @ml) for a 2 week period and tested 1 week after MPOA steroid implantation. After the experiment, the animals were decapitated and the brains were removed to verify cannulae placement.
After testing, the cannulae were removed and weighed, and in each case -40% of the steroid remained in the cannulae. This was also verified in a separate group of animals that were implanted bilaterally with cannulae containing ['H]B and unlabeled B (100,000 cpm [3H] B/100 pg unlabeled B) as described previously (Meaney and McEwen, 1986; Diorio et al., 1993) . The animals were killed 1 week after surgery, and [3H]B diffusion was assessed in microdissected tissue (1 mm punches) obtained from 300 pm brain sections and in median eminence, pituitary, and plasma (1 ml) samples. ["H]B was extracted from sonicated tissue samples with 500 ~1 of ethanol at 25°C. After extraction, the samples were centrifuged at 12,000 X g, and 250 ~1 aliquots of the extract were then counted in 5 ml of scintillation cocktail (Liquiscent, National Diagnostics, Sommerville, NJ). The remaining pellet was resonicated in aqueous solution, and protein concentrations were determined by the method of Bradford (1976) .
MPOA lesions. Bilateral electrolytic lesions of the MPOA were made under pentobarbital anesthesia using the same stereotaxic coordinates as described for the lesion studies. Anodal current (0.5 mA) was passed through a tungsten microelectrode for a 30 set period. Sham-lesioned animals received the same treatment as the lesioned animals without current flow. Animals were stressed 2 weeks after lesions. After testing, the animals were decapitated and the brains were removed to verify the extent of the MPOA lesions.
Radioimmunoussays. Plasma B (10 ~1) was measured by radioimmunoassay (RIA) (Krev et al., 1975 ) with a hiehlv soecific B antiserum (B31163, Endocrine Sciences, Tarzana, CA)-and ['H]B (101 Ci/mmol, DuPont NEN) as tracer. The antiserum cross-reacts slightly with desoxycorticosterone (-4%) but not with aldosterone, cortisol, or progesterone (cl%).
The intra-and interassay coefficients of variation were 8.8 and 10.4%, respectively.
Plasma ACTH (25 ~1) concentrations were measured by RIA as described previously (Viau and Meaney, 1991a; Viau et al., 1993) . Briefly, unextracted plasma was incubated overnight at 4°C with a specific ACTH antiserum at a final dilution of 1:120,000 (IgG Corporation, Nashville, TN) and ["'I]ACTH (Incstar, Stillwater, MN) as tracer (5000 cpmitube). The ACTH antibody cross-reacts 100% with ACTH,-a9, ACTH,-,s, and ACTH L-24 but not with ACTH,-,,, P-endorphin, 01-and P-melanocytestimulating hormone, or 01. and P-lipotropin (<I%). After 48 hr of additional incubation, precipitation serum (Antibodies, Davis, CA) was added, and bound peptide was obtained by centrifugation at 5000 x g for 45 min. The detection limit of the assay was 10 pgiml. The intra-and interassay coefficients of variation were 7.5 and 12.0%, respectively. Plasma T (25 ~1) was measured using the RIA kit of ICN Biomeclicals (Carson, CA) with 1'a511T as tracer. The T antibodv (solid chase) crossreacts slightly with &DHT (7.8%), 5a-androstane:3b, 17&diol (2.2%) and 11-oxotestosterone (2%) but does not cross-react with progesterone, estrogen, or the glucocorticoids (all <O.Ol%). The detection limit of the assay was 0.6 @ml. The intra-and interassay coefficients of variation were 3.5 and lO.O%, respectively.
Plasma-luteinizing hormone (LH; 75 ~1) was determined by RIA as described previously (Niswender et al., 1968) . Briefly, unextracted plasma was incubated at 4°C in PBS (pH 7.4) with LH standard (RP-2) and antiserum (rLH-S-10, 1:125,000) obtained from National Institutes of Health, and ['*'I]LH as tracer (15,000 cpmitube). The LH antibody cross-reacts 100% with LH fRP-2) and 6% with thvroid-stimulating hormone but not with follicle-stimulating hormone, proiactin, or growth hormone (all <0.2%). The detection limit of the assay was 0.02 @ml. The intra-and interassay coefficients of variation were 2.0 and 12%, respectively.
For median eminence CRH and AVP peptide determinations, the tissue fragments were homogenized in 0.1 N HCI buffer at 0°C containing 0.001% P-mercaptoethanol, 0.05% ascorbic acid, 0.01% bacitracin, and 0.001% phenylmethylsulfonyl fluoride at a ratio of 1 ml/median eminence (Vale et al., 1983) . A 200 ~1 aliquot was taken for protein determination before (PRE) and after the termination of 10 min of restraint stress (n = in intact animals. A, The relationship between T levels and the integrated 5; 5 and 6 animals/group, respectively). **p < 0.01; *p < 0.05 versus low ACTH response to restraint was best fit by the equationy = 288.3 -330.7
T and GDX animals. X log(x). B, The integrated B response to stress was also described by a logarithmic fit: y = 51.2 -47.2 X log(x).
by the method of Bradford (1976). Samples were centrifuged at 12,000 X g for 30 min, after which the supernatants were lyophilized and reconstituted in RIA buffer. CRH and AVP content were measured by RIA using specific antisera and ['*'I-Tyr']CRH and ["'I-Arg']AVP as tracer, respectively (Peninsula Laboratories, Belmont, CA). The CRH antibody (1:48,000) cross-reacts 100% with human/rat CRH, 36% with bovine CRH, and ~0.01% with ovine CRH and sauvagine, but it does not cross-react with LH-releasing hormone, ACTH, or [Arg'd-vasopressin. The AVP antibody (1:150,000) cross-reacts 100% with [Arg ]-vasopressin and [d(CH,) ,,p-Ile2,11e4,Arg8]-vasopressin and 0.8% with desamino-[DArg'l-vasopressin, but it does not cross-react with LHRH, ACTH, or oxy&in. The detection limit of both assays was 5 pgitube. The intra-assay coefficient of variation for both the CRH and the AVP RIAs was -5.0%. whereas the interassay coefficients were 11.2 and 13.0%, respectively.
Statistical analysis. Unless otherwise stated, the data were analyzed using a two-way ANOVA with Tukey's post hoc tests performed where appropriate. Integrated plasma ACTH and B levels (area under the curve) were calculated using the trapezoidal method (Tallarida and Murray, 1981) , which provided an index of total hormone responses to restraint. Integrated ACTH and B values are expressed as pgmg-'amin-' and p8dl-'emin-', respectively. Regression analyses were performed using the least-squares method.
RESULTS

HPA responses to restraint in intact and GDX animals
Intact animals were ranked according to their basal plasma T levels. The median T value was 1.8 rig/ml. Animals with T levels less than or greater than this value were grouped as low-or high-T animals, respectively. Peak ACTH and B responses to 10 min of restraint stress in intact animals with high basal T levels (group mean = 4.0 -C 0.6 r&ml) were significantly lower than those in IL 0 animals with low basal T levels (group mean = 1.2 2 0.3 @ml) or in GDX male rats (Fig. 1) . Interestingly, GDX and intact low-T animals showed comparable (p > 0.05) ACTH and B responses to restraint (Fig. 1 ). There were no differences in prestress (basal) levels of plasma ACTH or B as a function of T (Fig. 1) .
Analysis of individual integrated ACTH (pgml-'*min-') and B (pgdl-'emin-') responses to stress in intact animals showed a strong negative correlation (r = -0.80) between prestress levels of T and the integrated ACTH and B response to stress (Fig. 2) . The relationship between the integrated ACTH and B responses to stress and prestress levels of T was best described by a logarithmic fit 0, < 0.01). The plasma T levels needed to inhibit ACTH and B release were derived from the line of best fit and the maxima1 integrated ACTH and B responses to restraint. Based on the plasma T level corresponding to the half-maximal hormone response to stress, the corresponding IC,, values for T inhibition of ACTH and B were estimated to be -2.6 and 2.9 @ml, respectively.
HPA responses to restraint in GDX, T-replaced animals Plasma T levels in GDX, T-replaced rats approximated those found in intact animals. GDX, T-replaced animals were ranked according to their plasma T levels. The median T value was 2.6 @ml. Animals with T levels less than or greater than this value were grouped as low or high GDX, T-replaced animals, respectively. As a group, GDX, high T-replaced (5.1 2 0.6 rig/ml) animals showed significantly lower plasma ACTH (p < 0.01) responses to stress compared with animals with low T (1.7 ? 0.3 @ml) replacement levels (Fig. 3A) . Plasma B responses to stress were similarly affected by the level of T replacement, because high T-replaced animals showed significantly lower B responses to restraint compared with low T-replaced animals (Fig. 3B) . No significant differences were found in prestress basal levels of ACTH and B as a function of T replacement; however, the sampling procedure used here is not adequate to reflect clearly the potential differences in basal ACTH or B levels that fluctuate over a circadian rhythm. These data simply reflect the absence of any differences in ACTH or B at the time immediately before stress testing. Analysis of individual HPA responses to restraint in GDX, T-replaced animals further illustrated a relationship between plasma T levels and the integrated ACTH and B responses to stress (Fig. 4) . Thus, a strong negative correlation was found between the level of T replacement and the integrated ACTH (I = -0.79) and B (r = -0.71) responses to stress, described in both cases by a logarithmic fit 0, < 0.05). The corresponding IC,, values for T inhibition of ACTH and B in GDX animals were -3.9 and 3.1 @ml, respectively.
ACTH secretagogues in GDX, T-replaced animals There were no significant differences in median eminence CRH content as a function of T replacement (Fig. 5A) . T-replacement (x) . B, The integrated B response to stress was also described by a logarithmic fit: y = 41.7.2 -23.8 X log(x). levels in GDX animals, however, had a marked effect on median eminence AVP content. GDX, high T-replaced animals had significantly lower (P < 0.01) resting-state levels of AVP in the median eminence compared with those in low T-replaced animals (Fig. SB) . Regression analysis revealed a strong negative correlation (r = -0.80; p < 0.01) between prestress plasma T levels and AVP content in the median eminence (Fig. 6A) . Further analysis revealed a significant correlation (Y = 0.70; p < 0.01) between individual resting-state levels of AVP in the median eminence and the integrated ACTH response to restraint (Fig. 6B) . No clear relationship could be determined between individual resting-state levels of CRH and plasma ACTH responses to stress (r = 0.14; p > 0.05).
Corticosteroid
receptor binding in GDX, T-replaced animals No significant differences were found in mineralocorticoid receptor binding as a function of T replacement in the areas studied (Fig. 7B) . T replacement in GDX animals, however, had a tissuespecific effect on glucocorticoid receptor binding (Fig. 7A ). GDX animals with high plasma T-replacement levels showed significantly (JJ < 0.05) greater [3H]DEX binding in the MPOA compared with GDX animals with low T-replacement levels. Regression analysis (Fig. 8) showed a strong positive correlation between MPOA steroid implants Verification of cannula placement indicated that the cannula tips were located within the mediodorsal portion of the MPOA. All animals tested showed bilateral implants in this region. The results of the ['H]B diffusion study indicated that the distribution of radioactivity was confined to the preoptic area. Radioactivity levels in plasma, the bed nucleus of the stria terminalis, supraoptic nucleus (SON), suprachiasmatic nucleus (SCN), PVN, dorsal hippocampus, and median eminence did not significantly exceed background levels. Based on the atlas of Paxinos and Watson (1982) the absence of radioactivity in the SCN indicates that the extent of steroid diffusion was largely contained within a 0.5 mm area of the cannula tip. This is consistent with previous measures in our laboratory of [3H]B diffusion in the brain (Diorio et al., 1993) . Based on the known specific activity of radiolabeled B per cannula (see Materials and Methods), the concentration of B contained within the MPOA punch area was estimated to be 66 +-7 ng. Because T acts at the level of the MPOA to regulate LH release, we also measured plasma LH levels in these animals to verify the efficacy of the implants. Compared with levels in CHOL-implanted animals, plasma LH levels were significantly lower in animals bearing T implants in the MPOA (LH = 2.1 ? 0.5 vs 0.5 2 0.2 @ml; p < 0.05).
HPA activity in MPOA steroid-implanted animals Plasma ACTH and B responses to restraint were significantly reduced in animals with B and T implants in the MPOA compared with CHOL-treated controls (Fig. 9) . Peak ACTH levels were lower in both B-and T-implanted animals compared with those in CHOL animals (Fig. 9A) . This difference, however, was only significant (p < 0.05) between B and CHOL values. ACTH levels remained significantly lower in B-implanted animals for up to 30 min after restraint. Poststress ACTH levels in T-implanted animals were significantly lower (p < 0.05) than in CHOL-implanted animals at 10 and 20 min (Fig. 9A) . Integrated ACTH responses were significantly lower (p < 0.01) in B-and T-implanted animals compared with those in CHOL-implanted controls (Fig. 1aA) . The suppression of stress-induced ACTH release by both types of steroid implants is indicated further by the plasma (Fig. 9B) and integrated ( Fig. 1OB ) B responses to restraint. Thus, B responses to restraint were significantly (p < 0.01) reduced in B-and T-implanted animals compared with CHOL animals. There were no significant differences in prestress basal levels of plasma ACTH and B.
MPOA steroid implants did not alter median eminence CRH content. Thus, comparable tissue levels of CRH were observed in animals receiving B, T, or CHOL MPOA implants (Fig. 11A ). Both T and B implants, however, decreased median eminence AVP content. AVP peptide levels were significantly lower in animals with B (p < 0.01) and T (p < 0.05) MPOA implants compared with those in CHOL-implanted controls (Fig. 11B) . As in our previous study, regression analysis revealed a strong correlation between ACTH responses to restraint and resting-state median eminence levels of AVP (r = 0.77; p < 0.01) as a function of steroid implantation into the MPOA (Fig. 12) .
MPOA lesions
The extent of the electrolytic lesions was assessed in Nissl-stained sections (Fig. 13) . Damage was limited to the mediodorsal portion of the MPOA. Animals showing damage that was not bilateral were excluded from the study. The extent of the damage to the MPOA was also functionally assessed by measuring plasma LH levels from blood samples taken before stress testing. Plasma LH levels were below detectable limits (co.02 rig/ml) in GDX, MPOA-lesioned animals with or without high T replacement, whereas plasma LH levels in sham-lesioned and control high and low T-replaced GDX animals averaged 0.9 f 0.3, 0.8 ? 0.4, and 1.8 * 0.5 rig/ml, respectively.
HPA activity in MPOA-lesioned animals Consistent with an inhibitory effect of T on stress-related HPA activity, GDX animals with high T-replacement levels showed significantly (p < 0.01) lower plasma ACTH and B responses to restraint compared with low T-replaced animals (compare CTL T and CTL t, Fig. 14) . Peak ACTH responses to restraint were significantly higher in GDX, MPOA-lesioned animals with (Jr < 0.05) or without high T (p < 0.01) replacement compared with sham-lesioned and control animals provided with high T-replacement (Fig. 14A) era1 T levels on plasma ACTH responses to stress. Similar to the pattern of ACTH release, plasma B responses to restraint were significantly higher in MPOA-lesioned animals ( Fig. 14B ). High T replacement in MPOA-lesioned animals also failed to suppress the B response to stress; comparable plasma B levels occurred in MPOA-lesioned high T-replaced and control low T-replaced animals. The effects of MPOA lesions on T suppression of HPA activity during stress are illustrated further by the integrated ACTH and B responses to restraint (Fig. 15) . Lesions of the MPOA did not seem to alter basal HPA activity, because there were no significant differences in prestress levels of plasma ACTH and B.
DISCUSSION
Our results indicate that HPA responses to stress are sensitive to naturally occurring variations in circulating T levels. In both intact and GDX, T-replaced animals, ACTH and B responses to restraint were negatively correlated with individual plasma T levels. Note that the estimated IC,, values for T inhibition of ACTH and B release in GDX, T-replaced animals were higher than those for intact animals. Similarly, higher T-replacement levels are required to suppress plasma LH levels in castrated monkeys. Because circulating T normally fluctuates over a diurnal rhythm, delivery of T in a manner that mimics this diurnal rhythm may be more effective in suppressing stress-related HPA activity than constant levels of T replacement would be. Plasma T levels transiently increase or decrease after acute stress in rodents and primates (for review, see Rivier and Rivest, 1991) . Acute administration of T to intact animals immediately before restraint stress, however, does not alter ACTH and B release during restraint (our unpublished data). The strong negative correlation between HPA responses to restraint and prestress T levels in both intact and GDX, T-replaced animals also suggests that individual differences in stress-related HPA activity are regulated by basal T levels. Because GDX, T-replaced animals lack dynamic variations in T, the HPA response to stress is probably regulated by steady-state levels of T-regulated factors, such as hypothalamic AVP, that are involved in ACI'H release (see below). ACTH and B responses to restraint were comparable between GDX animals and intact males with low plasma T levels (-1 Damage to the MPOA was limited primarily to the mediodorsal part of the MPOA, including the median preoptic nucleus. The optic chiasm was spared in all cases. Damage to the MPOA extended rostrally to the level of the anterior commissure (-0.4 mm caudal to bregma) without involving any other structures. The caudal extent of the MPOA lesions was limited to but did not include the anterior hypothalamic area (-0.9 mm caudal to bregma). Analysis was based on the atlas of Paxinos and Watson (1982) . f, Fornix, mpo, medial preoptic area; ox, optic chiasm; 3V, third ventricle.
ngiml). This suggests that a minimum or threshold concentration of circulating T is required for inhibition of the HPA axis. This is reflected further by the logarithmic relationship observed between plasma T levels and stress-induced ACTH and B release. A similar relationship exists between T-replacement levels and LH levels, at which linear increases in plasma T levels produce a logarithmic decline in circulating LH concentrations (Dubey et al., 1984) . This relationship has been explained by the fact that T circulates either in a free state or bound to androgen-binding protein (ABP), which limits the access of T to its target sites (Dubey et al., 1984) . Free steroid levels dramatically increase when the capacity of the steroid-binding globulin is exceeded. Thus, linear increases in total plasma T concentrations over a range that approximates the Kd of the ABP would produce logarithmic increases in free T (analogous to the relationship between corticosteroid-binding globulin and B; Dallman et al., 1987) . This may account for the logarithmic relationship we observed between total plasma T levels and the integrated HPA responses to stress. The inhibitory effect of T on stress-induced ACTH release seems to involve changes in median eminence levels of AVP. GDX males with high T-replacement levels showed lower resting-state levels of AVP in the median eminence compared with those in GDX, low T-replaced animals, with no effect on CRH content. Based on the rather static measures used in this study, however, we cannot preclude the possibility of changes in CRH release in response to restraint stress. Content measures of median eminence AVP provide, for the most part, an index of magnocellular AVP activity. The inhibitory effects of high T-replacement levels in GDX animals on AVP content in the median eminence are consistent with the known inhibitory effects of T on plasma AVP and blood osmolality (Skowsky et al., 1979) . Magnocellular AVP constitutes an important source of AVP in pituitary portal plasma (for review, see Antoni, 1993) . Several studies reflect a positive relationship between the magnitude of the ACTH response to stress and the level of magnocellular AVP activity (Rittmaster et al., 1987; Irvine et al., 1989; Dohanics et al., 1991; Raff et al., 1991; Aguilera et al., 1993) . This is consistent with the strong correlation we observed between median eminence AVP and ACTH responses to stress. Although our measures largely reliect magnocellular AVP, this does not preclude the possibility of T-induced changes in the parvocellular AVP system. Moreover, T-replaced animals immediately before (PRE) and after the termination of 10 min restraint stress (n = 5,8,7,6, and 7 animals/group, respectively the correlational analysis could reflect parallel effects of T on plasma ACTH levels and magnocellular AVP, although the magnitude of the correlation within animals is certainly strong. Thus, at this time these findings simply suggest that T suppression of stressinduced ACTH release may be mediated by the inhibition of hypophysial AVP. Glucocorticoid receptor binding in the MPOA was increased in GDX males with high T-replacement levels compared with that in low T-replaced animals. This finding suggests that elevated T levels might increase the sensitivity of the MPOA to glucocorticoids. Taken together with the inhibitory effects of B implants into the MPOA on plasma ACTH and B responses to restraint, these findings suggest further that T may inhibit HPA responses to stress by enhancing glucocorticoid feedback at the level of the MPOA.
The data presented here certainly favor the MPOA as a critical site for the effects of T on HPA responses to stress. Plasma ACTH and B responses to restraint stress were decreased in animals bearing T implants in the MPOA. Moreover, in MPOA-lesioned responses to 10 min of restraint stress in MPOA-lesioned GDX animals without T replacement (Lesion + CHOL), MPOA-and sham-lesioned GDX high T-replaced animals (Lesion + T and Sham + T, respectively), and in GDX, high (CTL r) and low (CTL t) T-replaced animals (n = 5, 8, 7, 6, and 7 animals/group, respectively). **p < 0.01; *p < 0.05; versus Sham + T and CTL T.
animals, high peripheral T-replacement levels failed to inhibit ACTH and B release during restraint. The actions of both the B and the T implants into the MPOA on ACTH responses to stress were highly correlated with median eminence AVP levels. These findings suggest that T regulation of the HPA axis at the level of the MPOA may be dependent on circulating B levels. Basal plasma B levels in male rodents increase during the morning in response to estrogen implants into the MPOA (Telegdy, 1964) . Peripheral administration of estrogen in males increases ACTH and B release under basal as well as stressful conditions (Kitay, 1968) . In contrast, systemic T or T implants into the MPOA decrease HPA responses to stress. These differences between T and estrogen suggest that the effects of T on HPA activity are mediated via the androgen receptor. This distinction is important, considering the high amount of aromatase activity in the MPOA (Roselli, 1985) , and it merits further study using nonaromatizable androgens.
The MPOA sends extensive projections to several regions, including the PVN, the SON, and the internal zone of the median eminence (Swanson, 1976 (Swanson, , 1987 Simerly and Swanson, 1988; Cullinan et al., 1993) . These projections may explain the effects of the B and T implants in the MPOA on median eminence AVP content. Electrical stimulation of the MPOA increases PVN unit activity and plasma B levels (Redgate and Fahringer, 1973; Feldman, 1985, 1986) . Furthermore, iontophoretic injection of cortisol directly into the MPOA affects the cell firing rate in this region (Papir-Kricheli and Feldman, 1982) . Thus, the MPOA is functionally sensitive to glucocorticoids and is in a position to regulate the synthesis and stress-induced release of hypophysiotropic AVP. This is consistent with the effects of B and T MPOA implants on AVP median eminence levels and ACTH responses to restraint.
The MPOA also projects to the BNST and the amygdala (Swanson, 1976 (Swanson, , 1987 Palkovits, 1987) , structures that innervate the PVN and regulate HPA activity. Indirect pathways from the amygdala to the hypothalamus include the ventral amygdalofugal pathway, the BNST, and the MPOA, which in turn project to both parvocellular and magnocellular divisions of the PVN (for review, see Whitnall, 1993) . Because the MPOA receives and reciprocates input from the BNST and amygdala, the MPOA could modulate input to the PVN. This is consistent with the finding that MPOA lesions inhibit the increase in plasma B levels after electrical stimulation of the medial amygdala (Feldman et al., 1990) .
T has marked effects on the morphology of vasopressinergic projections of the BNST and the medial amygdaloid nucleus. Gonadectomy causes a decrease in AVP fiber densities in these regions, which is prevented by T replacement (De Vries et al., 1984 Urban et al., 1991) . Although these effects are the opposite of the T-dependent changes we observed in median eminence AVP content, intrahypothalamic vasopressinergic pathways seem to regulate the HPA axis negatively. AVP projections from the SCN inhibit unit activity in the PVN and the SON and decrease plasma B levels (Nicoll and Barker et al., 1971; Buijs, 1978; Hoorneman and Buijs, 1982; Hermes et al., 1991; Kalsbeek et al., 1992) . This suggests that the inhibitory effects of T on median eminence AVP content and plasma ACTH responses to stress could be functionally coupled to the positive effects of T on central AVP activity (i.e., inhibitory vasopressinergic projections to AVP neurons in the PVN). Thus, the effects of T on stressrelated HPA activity may not be exclusive to the MPOA.
Another neurotransmitter that may be involved in the suppressive effects of T on HPA activity is GABA. GABA innervation accounts for more than half of the synaptic inputs to the SON and PVN (Decavel and van den Pol, 1990; Roland and Sawchenko, 1993) . GABA input to magnocellular neurons of the SON originates in part from the median preoptic nucleus. Electrical stimulation of the median preoptic nucleus inhibits the activity of AVP-secreting neurons in the SON, and this effect is blocked by bicuculline, a GABA,-receptor antagonist (Nissen et al., 1991) . Thus, the inhibitory effects of T implants in the MPOA on median eminence AVP content and HPA responses to stress may be mediated by GABA. DEX suppression of stress-induced B release is blocked with mercaptopropionic acid, an inhibitor of GABA synthesis (Acs and Stark, 1978; Jones et al., 1984) . Injection of GABA directly into the median preoptic nucleus decreases plasma cortisol levels in the cat (Krieger and Krieger, 1970) . Finally, GABA turnover is decreased in the MPOA after gonadectomy (Grattan et al., 1992) . Taken together with our findings of effects of T on glucocorticoid receptor levels in the MPOA and the inhibitory effects of T implants in this region on plasma ACTH responses to restraint, this raises the possibility that T-dependent alterations in glucocorticoid feedback regulation of the HPA axis may involve B-and T-sensitive GABAergic neurons.
Stress studies have been lacking in the female because of the dynamic changes that occur in circulating estrogen and progesterone levels and the difficult task of assessing the relative contributions of these hormones to variation in HPA function. Thus, most
